Series on the Lancet Oncology Commission on Global Cancer Surgery: Introduction-Intent and Content.
Global cancer surgery
Inequities
Lancet oncology commission
Journal
Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840
Informations de publication
Date de publication:
03 Jun 2024
03 Jun 2024
Historique:
received:
01
05
2024
accepted:
15
05
2024
medline:
4
6
2024
pubmed:
4
6
2024
entrez:
3
6
2024
Statut:
aheadofprint
Résumé
Surgery plays a key role in the multi-disciplinary cancer care pathway. Nearly 80% of patients with solid tumors will require surgical intervention during the course of their disease. Unfortunately, the vast majority of these patients do not have access to safe, timely, high-quality, and affordable cancer surgical care. The first Lancet Oncology Commission on Global Cancer Surgery shone a light on this grave situation and outlined some strategies to address them. The second Lancet Oncology Commission on Global Cancer Surgery (TLO- II) was conceived to continue the work of its predecessor by developing a roadmap of practical solutions to propel improvements in cancer surgical care globally. The Commission was developed by involving approximately 50 cancer care leaders and experts from different parts of the world to ensure diversity of input and global applicability. The Commission identified nine solutional domains that are considered essential to deliver safe, timely, high-quality, and affordable cancer surgical care. These nine domains were further refined to develop solutions specific to each of the six World Health Organization regions. Based on the above solutions, we developed eight action items that are intended to propel improvements in cancer surgical care on the global stage. The second Lancet Oncology Commission on Global Cancer Surgery builds on the first Commission by developing a pragmatic roadmap of practical solutions that we hope will ensure access to safe, timely, high-quality, and affordable cancer surgical care for everyone regardless of their socioeconomic status or geographic location.
Sections du résumé
BACKGROUND
BACKGROUND
Surgery plays a key role in the multi-disciplinary cancer care pathway. Nearly 80% of patients with solid tumors will require surgical intervention during the course of their disease. Unfortunately, the vast majority of these patients do not have access to safe, timely, high-quality, and affordable cancer surgical care. The first Lancet Oncology Commission on Global Cancer Surgery shone a light on this grave situation and outlined some strategies to address them. The second Lancet Oncology Commission on Global Cancer Surgery (TLO- II) was conceived to continue the work of its predecessor by developing a roadmap of practical solutions to propel improvements in cancer surgical care globally.
METHODS
METHODS
The Commission was developed by involving approximately 50 cancer care leaders and experts from different parts of the world to ensure diversity of input and global applicability.
RESULTS
RESULTS
The Commission identified nine solutional domains that are considered essential to deliver safe, timely, high-quality, and affordable cancer surgical care. These nine domains were further refined to develop solutions specific to each of the six World Health Organization regions. Based on the above solutions, we developed eight action items that are intended to propel improvements in cancer surgical care on the global stage.
CONCLUSIONS
CONCLUSIONS
The second Lancet Oncology Commission on Global Cancer Surgery builds on the first Commission by developing a pragmatic roadmap of practical solutions that we hope will ensure access to safe, timely, high-quality, and affordable cancer surgical care for everyone regardless of their socioeconomic status or geographic location.
Identifiants
pubmed: 38831196
doi: 10.1245/s10434-024-15554-9
pii: 10.1245/s10434-024-15554-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. Society of Surgical Oncology.
Références
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660 .
doi: 10.3322/caac.21660
pubmed: 33538338
Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149(4):778–89.
doi: 10.1002/ijc.33588
Organization WH. Global health estimates 2020: deaths by cause, age, sex, by country and by region, 2000-2019. WHO Geneva, Switzerland; 2020.
National Center for Health Statistics. Deaths, percent of total deaths, and death rates for the 15 leading causes of death: United States and Each State, 2015–2017. Accessed Apr 21, 2024. https://www.cdc.gov/nchs/nvss/mortality/lcwk5_hr.htm
Khan HM, Ramsey S, Shankaran V. Financial toxicity in cancer care: implications for clinical care and potential practice solutions. J Clin Oncol. 2023;41(16):3051–8. https://doi.org/10.1200/jco.22.01799 .
doi: 10.1200/jco.22.01799
pubmed: 37071839
Bray F, Laversanne M, Sung H, et al. GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2022. https://doi.org/10.3322/caac.21834 .
doi: 10.3322/caac.21834
Kocarnik JM, Compton K, Dean FE, et al. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019. JAMA Oncol. 2022;8(3):420–44.
doi: 10.1001/jamaoncol.2021.6987
pubmed: 34967848
Sullivan R, Alatise OI, Anderson BO, et al. Global cancer surgery: delivering safe, affordable, and timely cancer surgery. Lancet Oncol. 2015;16(11):1193–224. https://doi.org/10.1016/s1470-2045(15)00223-5 .
doi: 10.1016/s1470-2045(15)00223-5
pubmed: 26427363
Perera SK, Jacob S, Wilson BE, et al. Global demand for cancer surgery and an estimate of the optimal surgical and anaesthesia workforce between 2018 and 2040: a population-based modelling study. Lancet Oncol. 2021;22(2):182–9. https://doi.org/10.1016/S1470-2045(20)30675-6 .
doi: 10.1016/S1470-2045(20)30675-6
pubmed: 33485458
Are C, Murthy SS, Sullivan R, et al. Global cancer surgery: pragmatic solutions to improve cancer surgery outcomes worldwide. Lancet Oncol. 2023;24(12):e472-518. https://doi.org/10.1016/s1470-2045(23)00412-6 .
doi: 10.1016/s1470-2045(23)00412-6
pubmed: 37924819
Geneva: World Health Organization. WHO global survey on the inclusion of cancer care in health-benefit packages, 2020–2021. 2024. https://iris.who.int/bitstream/handle/10665/375828/9789240088504-eng.pdf?sequence=1 .
Mutebi M, Dehar N, Nogueira LM, et al. Cancer groundshot: building a robust cancer control platform in addition to launching the cancer moonshot. Am Soc Clin Oncol Educ Book. 2022;42:100–15.
doi: 10.1200/EDBK_359521
Gyawali B, Sullivan R, Booth CM. Cancer groundshot: going global before going to the moon. Lancet Oncol. 2018;19(3):288–90.
doi: 10.1016/S1470-2045(18)30076-7
pubmed: 29508746
Asbun HJ, Moekotte AL, Vissers FL, et al. The Miami International evidence-based guidelines on minimally invasive pancreas resection. Ann Surg. 2020;271(1):1–14. https://doi.org/10.1097/sla.0000000000003590 .
doi: 10.1097/sla.0000000000003590
pubmed: 31567509
Liu R, Wakabayashi G, Kim HJ, et al. International consensus statement on robotic hepatectomy surgery in 2018. World J Gastroenterol. 2019;25(12):1432–44. https://doi.org/10.3748/wjg.v25.i12.1432 .
doi: 10.3748/wjg.v25.i12.1432
pubmed: 30948907
pmcid: 6441912
Higgins RM, Frelich MJ, Bosler ME, Gould JC. Cost analysis of robotic versus laparoscopic general surgery procedures. Surg Endosc. 2017;31(1):185–92. https://doi.org/10.1007/s00464-016-4954-2 .
doi: 10.1007/s00464-016-4954-2
pubmed: 27139704
Kim HI, Han SU, Yang HK, et al. Multicenter prospective comparative study of robotic versus laparoscopic gastrectomy for gastric adenocarcinoma. Ann Surg. 2016;263(1):103–9. https://doi.org/10.1097/SLA.0000000000001249 .
doi: 10.1097/SLA.0000000000001249
pubmed: 26020107
Damschroder LJ, Aron DC, Keith RE, et al. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4(1):50. https://doi.org/10.1186/1748-5908-4-50 .
doi: 10.1186/1748-5908-4-50
pubmed: 19664226
pmcid: 2736161
Damschroder LJ, Reardon CM, Widerquist MAO, Lowery J. The updated consolidated framework for implementation research based on user feedback. Implement Sci. 2022. https://doi.org/10.1186/s13012-022-01245-0 .
doi: 10.1186/s13012-022-01245-0
pubmed: 36309746
pmcid: 9617234
Consolidated Framework for Implementation Research. Updated CFIR constructs. Accessed Dec 2022. https://cfirguide.org/constructs/ .